Collexis Selected as Knowledge Platform for the National Institutes of Health

COLUMBIA, South Carolina, July 10 /PRNewswire/ --

- Significant Client Development for Knowledge Discovery Company

Following the announcement of the company's public listing, Collexis 
(OTC Bulletin Board: CLXS) has signed an Enterprise License Agreement and 
ongoing engagement with the National Institutes of Health (NIH), replacing 
the Company's prior license with NIH. The National Institutes of Health is 
the largest funder of health sciences research in the world. Over US$20B a 
year in federal grant funding will now be analyzed by the Collexis platform. 
The agreement also enables all the NIH Institutes to utilize the company's
software for categorization, search, expertise identification, discovery and
analysis of text-based content. Content examples include publications,
grants, patents and other scientific works and information.

"We are very excited about our relationship with the NIH and are
confident Collexis will be a valuable asset to its 27 institutions. The
Collexis analysis of grant content fits with the NIH's Roadmap toward a
digital future in research. Our software will help increase efficiency,
consistency and transparency as it pertains to the Institutes' needs," said
Bill Kirkland, CEO, Collexis Holdings, Inc.

This arrangement represents an important milestone for Collexis and adds
another elite, first-mover institution to the ranks of those who have adopted
Collexis' research software, including Johns Hopkins University, Harvard
University, Morehouse School of Medicine, University of California, San
Francisco, University of South Carolina, Bristol-Myers Squibb, Merck & Co.
Inc., Lockheed Martin, the World Health Organization, Wellcome Trust, and
others. "With the addition of NIH and Wellcome Trust, Collexis has now become
the grants categorization, management and reporting standard for the largest
public and largest private health science research funders in the world,"
stated Steve Leicht, Collexis VP of Sales. "The NIH has their pick of the
best technology. We are gratified that NIH has used its expertise, time and
talent to do the necessary examination and comparison and has selected
Collexis as its provider of text analysis software. Clearly, Collexis is at
the leading edge of the marketplace," Leicht added.

The Collexis application suite fingerprints private and public health
sciences databases including PubMed, Grants.gov, Clinical Trials data, Web
Data and other sources/publications, as well as internal corporate and
enterprise content for analysis.

Collexis Holdings, Inc.

Collexis Holdings, Inc., a global knowledge discovery company since 1999,
is headquartered in Columbia, South Carolina (USA) with two subsidiaries;
Collexis Inc. in Columbia, South Carolina, USA and Collexis, B.V. in
Geldermalsen, The Netherlands. Collexis' patented technology builds
conceptual profiles of text, called Fingerprints, from documents, websites,
e-mails and other digitized content to create applications. The results are
often described as "finding needles in many haystacks." Through this novel
approach, Collexis can build unique applications to search, index, and
aggregate information as well as prioritize, trend and predict data based on
sources in multiple fields, without the limitations of language or dialect.
The company's mission is to develop software supporting knowledge retrieval
and discovery across multiple industries. For more information visit
www.collexis.com.

This press release contains forward-looking statements. Such statements
are valid only as of today, and we disclaim any obligation to update this
information. These statements are subject to known and unknown risks and
uncertainties that may cause actual future experience and results to differ
materially from the statements made. These statements are based on our
current beliefs and expectations as to future outcomes. Factors that could
affect future performance include business and economic trends, the ability
to continue funding operating losses, fluctuations in operating results,
continued success in developing our research software and other risk factors
as disclosed in our public filings with the Securities and Exchange
Commission.

National Institutes of Health (NIH) is not considered a supporter or
partner of Collexis. Reference to NIH in the above shall not be construed as
a Government endorsement nor does it obligate NIH to a position on or about
the Collexis Software.

Web site: http://www.collexis.com